Linkage Projects - Grant ID: LP0455698

Funding Activity

Website
http://dataportal.arc.gov.au/NCGP/Web/Grant/Grant/LP0455698

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Novel lipid-based adjuvants for induction of mucosal immunity. The project will determine if needle-free oral and transcutaneous immunisation using LipoVax, a novel lipid-based antigen delivery system developed by the industry partner, can protect mice against the mucosal pathogens Chlamydia and Helicobacter. We expect to show that this immunisation method can induce protective mucosal immunity against two of the most common infectious organisms affecting mankind. If successful this will allow us to develop LipoVax as a new platform technology that can be applied to the development of human vaccines, veterinary vaccines, vaccines for companion animals and vaccines to target infections in feral animals and native wildlife population populations.

Funded Activity Details

Start Date: 21-04-2005

End Date: 13-06-2009

Funding Scheme: Linkage Projects

Funding Amount: $100,668.00

Funder: Australian Research Council

Research Topics

ANZSRC Field of Research (FoR)

Infectious Diseases | Immunology | Immunology | Immunology Not Elsewhere Classified

ANZSRC Socio-Economic Objective (SEO)

Immune system and allergy | Infectious diseases | Prevention—biologicals (e.g. vaccines) |

Other Keywords

Immune system and allergy | Immunology | Immunology Not Elsewhere Classified | Infectious Diseases | Infectious diseases | Prevention—biologicals (e.g. vaccines)

Related Links